Stress Axis Downregulation describes the clinical goal of reducing the chronic, excessive signaling activity within the Hypothalamic-Pituitary-Adrenal (HPA) axis, often resulting from prolonged psychological or physiological stressors. This process seeks to restore the normal diurnal rhythm of cortisol secretion and reduce the overall allostatic load placed upon the system. Successful downregulation is paramount for preventing fatigue and metabolic dysfunction.
Origin
This concept stems from stress physiology, where chronic stimulation leads to adaptive changes in receptor sensitivity and feedback mechanisms within the HPA axis. Downregulation implies actively decreasing the gain or sensitivity of the signaling cascade.
Mechanism
Interventions target the reduction of upstream activators, such as CRH signaling, or enhancing the negative feedback exerted by cortisol on the pituitary and hypothalamus. Furthermore, supporting adrenal cellular resilience ensures that the glands are not depleted by sustained demand. Modulating systemic inflammation is also a key component, as inflammatory cytokines can potentiate HPA axis activity.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.